Leaderna Therapeutics
Latest round
- Series A
Last raised
- Aug 2026
Total raised
- $22M
Investors
- 11
About Leaderna Therapeutics
, trading as Leaderna Therapeutics, provides synthetic oligonucleotide drug research and development for the biotechnology industry. The company operates a full chain platform covering target validation, lead compound screening, and formulation development. The chairman and general manager is Dr. Jinqiao Wan. The company works with the healthcare sector to provide innovative therapies for chronic diseases. A team of researchers and scientists develops small nucleic acid drugs utilizing proprietary technology platforms such as NEATL (novel delivery and nucleic acid enhancement), LOCATED (lipid-conjugated extrahepatic delivery), and DIRECT (single-molecule dual target interference). The company generates revenue from the research, development, and commercialization of its small nucleic acid drugs.
Who invested in Leaderna Therapeutics
11 investors across 2 rounds
See all investors in Leaderna Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Leaderna Therapeutics
Who invested in Leaderna Therapeutics?
Leaderna Therapeutics has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Leaderna Therapeutics raised?
Leaderna Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Leaderna Therapeutics last raise money?
Leaderna Therapeutics's most recent round on record is a Series A, in Aug 2026.
What does Leaderna Therapeutics do?
, trading as Leaderna Therapeutics, provides synthetic oligonucleotide drug research and development for the biotechnology industry.
Where is Leaderna Therapeutics headquartered?
Leaderna Therapeutics is headquartered in Chengdu, China.
Which VCs invest in companies like Leaderna Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Leaderna Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Leaderna Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.